Global Healthcare

Evidence Based Investing

scroll

Portfolio Characteristics

Inception Date – April 2019
Currency – USD
Dividend Yield – 1.85%
Daily Liquidity

Investment Approach

Evidence Based Investing is our core investment philosophy, which means that rather than relying on short-term forecasting, we draw information about expected returns from the market itself. Letting markets do what they do best, drive information into prices, frees us up to spend time where we believe we have an advantage, namely in how we interpret the research and how we design and manage portfolios. It means we take a more systematic approach to investing, an approach we can implement consistently, and investors can understand and stick with, even in challenging market environments.

Rigorous, unbiased research has yielded six expected return premia for patient investors, which are equity premium, small cap premium, value premium, profitability premium, term premium and credit premium. We then select the most suitable securities to create the desired market exposure in the most cost and tax efficient way to capture these premiums.

We manage investment risks by using the combined powers of diversification and asset allocation. Diversification is a way to dampen risks. While some risks can be diversified away, market risk however remains and is expected to enhance your long-term returns if you build them into your total portfolio, and if you stay the course with them over time.

Asset allocation is determined by the investor’s specific goals and times frames and guided by his or her risk tolerance and capacity.

Strategy Description

The strategy uses a bottom-up stock picking approach to create a concentrated portfolio of global healthcare stocks.

The sector is currently attractively valued compared to its growth prospects.

The research process is focused on finding companies that show relative value and quality characteristics within the sector. Our research models screen the global stock universe in a disciplined way based on 27 model factors and select the companies that have the highest return expectations. The portfolio is regularly rebalanced based on those factors.

Portfolio Performance

YTD 2020 2019
Portfolio 1.63% 13.72% 0.03%
as of 29/01/2021

Annualised Return

Standard Deviation

Sharpe Ratio

Portfolio 8.23% 18.87% 0.44%

Allocation

America 57.99%

Greater Europe 20.41%

Developed Asia 21.60%

Emerging Asia 0.00%

Central/Latin America 0.00%

Sector

Financials

0.00%

Industrials

0.00%

Consumer Discretinoary

0.00%

Real Estate

0.00%

Consumer Staples

0.00%

Materials

0.00%

Healthcare

100.00%

Utilities

0.00%

Technology

0.00%

Energy

0.00%

Telecommunication

0.00%

Sector

Financials

0.00%

Industrials

0.00%

Consumer Discretinoary

0.00%

Real Estate

0.00%

Consumer Staples

0.00%

Materials

0.00%

Healthcare

100.00%

Utilities

0.00%

Technology

0.00%

Energy

0.00%

Telecommunication

0.00%

Sector

Investment Grade

null

High Yield

0.00%

Other

0.00%

Financials

0.00%

Industrials

0.00%

Consumer Discretionary

0.00%

Real Estate

0.00%

Consumer Staples

0.00%

Materials

0.00%

Healthcare

100.00%

Utilites

0.00%

Technology

0.00%

Energy

0.00%

Communication

0.00%

Sector

Diversified Reits

null

Office Reits

0.00%

Retail Reits

0.00%

Hotel & Resort Reits

0.00%

Industrial Reits

0.00%

Financials

0.00%

Industrials

0.00%

Consumer Discretionary

0.00%

Real Estate

0.00%

Consumer Staples

0.00%

Materials

0.00%

Healthcare

100.00%

Utilites

0.00%

Technology

0.00%

Energy

0.00%

Communication

0.00%

Top Holdings

StockWeight

Eli Lilly and Co8.09%

Chugai Pharmaceutical Co Ltd6.64%

M3 Inc6.41%

AbbVie Inc6.40%

Hansoh Pharmaceutical Group Co Ltd6.20%

Johnson & Johnson6.00%

Astellas Pharma Inc5.91%

Hoya Corp5.67%

Amgen Inc5.63%

Vertex Pharmaceuticals Inc5.50%

Start a conversation

Whether you are looking for a second opinion, have more questions, or are ready to become a client, we’re here to help.